Saffron, United Kingdom

Paul Stuart Hinchliffe


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Saffron Walden, GB (2015)
  • Saffron, GB (2015 - 2018)

Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Paul Stuart Hinchliffe: Innovator in Pharmaceutical Advancements

Introduction

Paul Stuart Hinchliffe is a notable inventor based in Saffron, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on FSH receptor antagonists. With a total of three patents to his name, Hinchliffe's inventions are aimed at addressing critical health issues.

Latest Patents

Hinchliffe's latest patents focus on FSH receptor antagonists, which are compounds designed to inhibit the action of the follicle-stimulating hormone (FSH). These inventions are described by a general formula and include pharmaceutically acceptable salts. The pharmaceutical compositions developed from these compounds can be utilized for the treatment and prevention of endometriosis, pre-menopausal and peri-menopausal hormone-dependent breast cancer, contraception, and the treatment of uterine fibroids and other menstrual-related disorders.

Career Highlights

Hinchliffe is currently associated with Merck Sharp & Dohme B.V., where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions that address significant medical challenges.

Collaborations

Throughout his career, Hinchliffe has collaborated with esteemed colleagues such as Wesley Peter Blackaby and Martin De Kort. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.

Conclusion

Paul Stuart Hinchliffe stands out as a prominent inventor in the pharmaceutical industry, with a focus on innovative treatments for women's health issues. His contributions through patents and collaborations reflect his commitment to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…